| Date Filed | Type | Description |
| 08/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2023 |
3/A
| Brenner Randall B. (Chief Development & Regulatory) has filed a Form 3/A on Paratek Pharmaceuticals, Inc. |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/23/2023 |
4
| Stein Jeffrey (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 7,000 shares
@ $1.9, valued at
$13.3k
|
|
| 02/23/2023 |
4
| Franson Timothy R (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 7,000 shares
@ $1.88, valued at
$13.2k
|
|
| 02/09/2023 |
4
| Stein Jeffrey (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/09/2023 |
4
| Radie Robert S (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/09/2023 |
4
| Peterson Kristine (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/09/2023 |
4
| Hoffmann Rolf K (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/09/2023 |
4
| Franson Timothy R (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/09/2023 |
4
| Dietz Thomas John (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 02/09/2023 |
4
| Baylor-Henry Minnie (Director) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 12/22/2022 |
4
| Woodrow Adam (President & Chief Commercial) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 22,500 shares
@ $0
Sold 6,750 shares
@ $1.99, valued at
$13.4k
|
|
| 12/22/2022 |
4
| Loh Evan (CEO) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 52,500 shares
@ $0
Sold 23,489 shares
@ $1.99, valued at
$46.7k
|
|
| 12/22/2022 |
4
| Haskel William M. (CLO, General Counsel & Sec.) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Sold 7,007 shares
@ $1.99, valued at
$13.9k
|
|
| 12/22/2022 |
4
| Brenner Randall B. (Chief Development & Regulatory) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Sold 4,539 shares
@ $1.99, valued at
$9k
|
|
| 12/22/2022 |
4
| BIGHAM MICHAEL (Exec. Chairman of the Board) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Granted 45,000 shares
@ $0
Sold 15,750 shares
@ $1.99, valued at
$31.3k
|
|
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| BIGHAM MICHAEL (Exec. Chairman of the Board) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 19,484 shares
@ $1.98, valued at
$38.6k
Sold 31,891 shares
@ $1.96, valued at
$62.5k
|
|
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| BIGHAM MICHAEL (Exec. Chairman of the Board) has filed a Form 4 on Paratek Pharmaceuticals, Inc.|
Txns:
| Sold 6,000 shares
@ $3.47, valued at
$20.8k
|
|
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|